News

Oophorectomy Halves Risk of Contralateral Breast Cancer with BRCA Mutations

Publish date: October 6, 2010

 

FROM A BREAST CANCER SYMPOSIUM SPONSORED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY

The authors reported that they have no relevant financial relationships.

Pages

Recommended Reading

Guidelines: Prophylactic BSO Warranted for High Risk of Ovarian Cancer
MDedge Internal Medicine
Malnutrition Widespread in Cancer Patients; Counseling Prolongs Survival
MDedge Internal Medicine
Prostate Cancer Treatments' Quality of Life Effects Differ Long Term
MDedge Internal Medicine
Progesterone Therapy via IUD Plus GnRH Can Save Fertility in Endometrial Cancer
MDedge Internal Medicine
IGF-1 Receptor May Present Therapeutic Target in Triple-Negative Breast Cancer
MDedge Internal Medicine
10-Year Breast Cancer Survival Rates Improve
MDedge Internal Medicine
Breast Cancer Mortality Reduced by 26% With Mammography
MDedge Internal Medicine
Mitomycin C Offers Alternative, but Cisplatin-Based Chemoradiation Remains Standard in Head and Neck Cancer
MDedge Internal Medicine
Age, Tumor Characteristics Predict Locoregional Failure After Neoadjuvant Breast Cancer Therapy
MDedge Internal Medicine
Regional Hyperthermia Plus Chemo Helps High-Risk, Nonextremity, Soft Tissue Sarcomas
MDedge Internal Medicine